Homework Help is Here – Start Your Trial Now!
Science
Chemistry
225 AC 9.9d 221Fr deday hhoun minutes econds msmillseconds eroseconds 4.8 m x1 32 ms X2 X3 42 ya 45.6 m X4 X5 |209BI 2.2m 3.3h stable This figure' shows that the decay "chain" starts with an a decay of Ac to produce 2Fr, which itself undergoes a decay to "X1", and so on, until the final production of the stable *Bi isotope via a beta- decay process from "XS". Note that isotope "X2" has two different decay channels, both of which result in "XS": 98% of "X2" undergoes B' decay to "X3" (which subsequently decays by emitting a to produce "XS"), while 2% of "X2" decays to "X4" via a decay (which subsequently undergoes B' decay to "XS"). 1. Given the type of decay process, provide the element and nucleon number (e.g. 2"iFr) for each of the isotopes X1, X2, X3, X4 and XS. 2. Assume a chemist in Dr. Ramogida's lab requires 8 hours from the time of receipt of 2Ac to incorporate it into a chemically synthesized carrier compound that can be used for cancer treatment. If they are given 0.450 mg of 22Ac, what is the mass of 2*Ac remaining at the end of the 8 hours, given its half-life of 9.9 days? 3. If their compound is shipped around the world for treatment of cancer patients, a key consideration is how long it remains active. Starting with the amount that leaves Dr. Ramogida's lab, for how long does at least 10% of the Ac remain, which could be used for treatment?

225 AC 9.9d 221Fr deday hhoun minutes econds msmillseconds eroseconds 4.8 m x1 32 ms X2 X3 42 ya 45.6 m X4 X5 |209BI 2.2m 3.3h stable This figure' shows that the decay "chain" starts with an a decay of Ac to produce 2Fr, which itself undergoes a decay to "X1", and so on, until the final production of the stable *Bi isotope via a beta- decay process from "XS". Note that isotope "X2" has two different decay channels, both of which result in "XS": 98% of "X2" undergoes B' decay to "X3" (which subsequently decays by emitting a to produce "XS"), while 2% of "X2" decays to "X4" via a decay (which subsequently undergoes B' decay to "XS"). 1. Given the type of decay process, provide the element and nucleon number (e.g. 2"iFr) for each of the isotopes X1, X2, X3, X4 and XS. 2. Assume a chemist in Dr. Ramogida's lab requires 8 hours from the time of receipt of 2Ac to incorporate it into a chemically synthesized carrier compound that can be used for cancer treatment. If they are given 0.450 mg of 22Ac, what is the mass of 2*Ac remaining at the end of the 8 hours, given its half-life of 9.9 days? 3. If their compound is shipped around the world for treatment of cancer patients, a key consideration is how long it remains active. Starting with the amount that leaves Dr. Ramogida's lab, for how long does at least 10% of the Ac remain, which could be used for treatment?

Chemistry
Chemistry
10th Edition
ISBN:9781305957404
Author:Steven S. Zumdahl, Susan A. Zumdahl, Donald J. DeCoste
Publisher:Steven S. Zumdahl, Susan A. Zumdahl, Donald J. DeCoste
Chapter1: Chemical Foundations
Section: Chapter Questions
Problem 1RQ: Define and explain the differences between the following terms. a. law and theory b. theory and...
See similar textbooks
icon
Related questions
Question

Question 3 please

|225 дс| 9.9 d a 221Fr d = days h = hours 4.8 m m = minutes s = seconds a ms = milliseconds us = microseconds X1 32 ms a X2 X3 98% B" 45.6 m 4.2 us 2% a |209Bİ B- X4 X5 2.2 m 3.3 h stable This figure' shows that the decay "chain" starts with an a decay of 225Ac to produce 221Fr, which itself undergoes a decay to "X1", and so on, until the final production of the stable 20°B¡ isotope via a beta- decay process from "X5". Note that isotope "X2" has two different decay channels, both of which result in "X5": 98% of “X2" undergoes B decay to "X3" (which subsequently decays by emitting a to produce "X5"), while 2% of "X2" decays to "X4" via a decay (which subsequently undergoes B" decay to "X5"). 1. Given the type of decay process, provide the element and nucleon number (e.g. 22"Fr) for each of the isotopes X1, X2, X3, X4 and X5. Assume a chemist in Dr. Ramogida's lab requires 8 hours from the time of receipt of 225 2. Ac to incorporate it into a chemically synthesized carrier compound that can be used for cancer treatment. If they are given 0.450 mg of 225 Ac, what is the mass of 225 Ac remaining at the end of the 8 hours, given its half-life of 9.9 days? 3. If their compound is shipped around the world for treatment of cancer patients, a key consideration is how long it remains active. Starting with the amount that leaves Dr. Ramogida's lab, for how long does at least 10% of the 225Ac remain, which could be used for treatment? The half-life of 221Fr is considerably shorter than 225AC: 4.8 minutes. Would you recommend to Dr. Ramogida's team to try to synthesize molecules that can target Francium to tumours, rather than using Actinium? Explain your reasoning. 4. "Figure adapted from "Development of 225AC Radiopharmaceuticals: TRIUMF Perspectives and Experiences", by Robertson, Ramogida, Schaffer and Radchenko. Current Radiopharmaceuticals 11, 156 (2018)
Transcribed Image Text:|225 дс| 9.9 d a 221Fr d = days h = hours 4.8 m m = minutes s = seconds a ms = milliseconds us = microseconds X1 32 ms a X2 X3 98% B" 45.6 m 4.2 us 2% a |209Bİ B- X4 X5 2.2 m 3.3 h stable This figure' shows that the decay "chain" starts with an a decay of 225Ac to produce 221Fr, which itself undergoes a decay to "X1", and so on, until the final production of the stable 20°B¡ isotope via a beta- decay process from "X5". Note that isotope "X2" has two different decay channels, both of which result in "X5": 98% of “X2" undergoes B decay to "X3" (which subsequently decays by emitting a to produce "X5"), while 2% of "X2" decays to "X4" via a decay (which subsequently undergoes B" decay to "X5"). 1. Given the type of decay process, provide the element and nucleon number (e.g. 22"Fr) for each of the isotopes X1, X2, X3, X4 and X5. Assume a chemist in Dr. Ramogida's lab requires 8 hours from the time of receipt of 225 2. Ac to incorporate it into a chemically synthesized carrier compound that can be used for cancer treatment. If they are given 0.450 mg of 225 Ac, what is the mass of 225 Ac remaining at the end of the 8 hours, given its half-life of 9.9 days? 3. If their compound is shipped around the world for treatment of cancer patients, a key consideration is how long it remains active. Starting with the amount that leaves Dr. Ramogida's lab, for how long does at least 10% of the 225Ac remain, which could be used for treatment? The half-life of 221Fr is considerably shorter than 225AC: 4.8 minutes. Would you recommend to Dr. Ramogida's team to try to synthesize molecules that can target Francium to tumours, rather than using Actinium? Explain your reasoning. 4. "Figure adapted from "Development of 225AC Radiopharmaceuticals: TRIUMF Perspectives and Experiences", by Robertson, Ramogida, Schaffer and Radchenko. Current Radiopharmaceuticals 11, 156 (2018)
Expert Solution
steps

Step by step

Solved in 2 steps with 1 images

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Nuclear Reactions
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, chemistry and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Chemistry
Chemistry
Chemistry
ISBN:
9781305957404
Author:
Steven S. Zumdahl, Susan A. Zumdahl, Donald J. DeCoste
Publisher:
Cengage Learning
Chemistry
Chemistry
Chemistry
ISBN:
9781259911156
Author:
Raymond Chang Dr., Jason Overby Professor
Publisher:
McGraw-Hill Education
Principles of Instrumental Analysis
Principles of Instrumental Analysis
Chemistry
ISBN:
9781305577213
Author:
Douglas A. Skoog, F. James Holler, Stanley R. Crouch
Publisher:
Cengage Learning
Organic Chemistry
Organic Chemistry
Chemistry
ISBN:
9780078021558
Author:
Janice Gorzynski Smith Dr.
Publisher:
McGraw-Hill Education
Chemistry: Principles and Reactions
Chemistry: Principles and Reactions
Chemistry
ISBN:
9781305079373
Author:
William L. Masterton, Cecile N. Hurley
Publisher:
Cengage Learning
Elementary Principles of Chemical Processes, Bind…
Elementary Principles of Chemical Processes, Bind…
Chemistry
ISBN:
9781118431221
Author:
Richard M. Felder, Ronald W. Rousseau, Lisa G. Bullard
Publisher:
WILEY
SEE MORE TEXTBOOKS